The bone morphogenetic protein–hepcidin axis as a therapeutic target in inflammatory bowel disease
Lijian Wang(Massachusetts General Hospital), Bobby J. Cherayil(Harvard University), Estela Trebicka(Massachusetts General Hospital), Jodie L. Babitt(Massachusetts General Hospital), Shiri Ellenbogen(Massachusetts General Hospital), Charles C. Hong(Vanderbilt University), Herbert Y. Lin(Harvard University), Ying Fu(Baker Heart and Diabetes Institute)
Cited by 64
Related Papers
Local proliferation dominates lesional macrophage accumulation in atherosclerosis
|Nature Medicine|2013|1k
On-demand erythrocyte disposal and iron recycling requires transient macrophages in the liver
|Nature Medicine|2016|413
Human Immunodeficiency Virus Impairs Reverse Cholesterol Transport from Macrophages
|PLoS Biology|2006|336